dabigatran has been researched along with Dyspepsia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 9 (81.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christory, F; Connolly, SJ; Dan, GA; Hatala, R; Huber, K; Kher, A; Kiss, RG; Klun, NV; Meier, B; Merkely, B; Pieske, B; Potpara, T; Stępińska, J; Vinereanu, D; Widimský, P | 1 |
| Eikelboom, JW; Robinson, M; Schulman, S; Shortt, B | 1 |
| Bianchi, V; Calabrò, P; Cavallaro, C; D'Onofrio, A; De Vivo, S; Nigro, G; Russo, V; Santangelo, L; Sarubbi, B; Vecchione, F | 1 |
| Aksoy, H; Ata, N; Ayturk, M; Dal, K; Ozkan, S; Ozturk, M; Şabanoglu, C; Tanalp, AC; Topaloglu, C; Yavuz, B; Yavuz, BB | 1 |
| Belletrutti, M; Cronin, L; Haertter, S; Halton, JM; Lehr, T; Lobmeyer, MT; Mitchell, LG | 1 |
| Agnelli, G; Aita, A; Becattini, C; Conti, S; Giustozzi, M; Molini, G; Pierpaoli, L; Valecchi, F; Vedovati, MC; Verdecchia, P | 1 |
| Alings, M; Connolly, SJ; Darius, H; Diaz, R; Diener, HC; Eikelboom, J; Ezekowitz, MD; Joyner, CD; Lewis, BS; Oldgren, J; Parekh, A; Pogue, J; Reilly, PA; Themeles, E; Varrone, J; Wallentin, L; Wang, S; Xavier, D; Yusuf, S; Zhu, J | 1 |
| Hankey, GJ | 1 |
| Gállego, J; Gil Alzueta, MC | 1 |
| Galle, PR; Hoffman, A | 1 |
| Aisenberg, J; Bytzer, P; Connolly, SJ; Ezekowitz, M; Formella, S; Reilly, PA; Yang, S | 1 |
3 review(s) available for dabigatran and Dyspepsia
| Article | Year |
|---|---|
Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Drug Interactions; Dyspepsia; Electric Countershock; Hemorrhage; Humans; Myocardial Infarction; Patient Selection; Pyridines; Randomized Controlled Trials as Topic; Stents; Stroke; Treatment Outcome | 2013 |
[Dabigatran: a new therapeutic alternative in the prevention of stroke].
Topics: Antithrombins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Atrial Fibrillation; Benzimidazoles; Clinical Trials, Phase III as Topic; Dabigatran; Double-Blind Method; Drug Interactions; Dyspepsia; Follow-Up Studies; Hemorrhage; Humans; Pyridines; Randomized Controlled Trials as Topic; Risk; Stroke; Tissue Plasminogen Activator | 2012 |
Gastrointestinal disorders and dabigatran.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Dyspepsia; Humans; Pyridines; Stroke | 2013 |
3 trial(s) available for dabigatran and Dyspepsia
| Article | Year |
|---|---|
Safety, tolerability and clinical pharmacology of dabigatran etexilate in adolescents. An open-label phase IIa study.
Topics: Administration, Oral; Adolescent; Antithrombins; Dabigatran; Dose-Response Relationship, Drug; Dyspepsia; Female; Humans; Male; Prodrugs; Venous Thromboembolism | 2016 |
Dabigatran versus warfarin in patients with atrial fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Chi-Square Distribution; Dabigatran; Double-Blind Method; Dyspepsia; Embolism; Female; Follow-Up Studies; Hemorrhage; Humans; Liver; Male; Middle Aged; Myocardial Infarction; Prodrugs; Proportional Hazards Models; Pyridines; Stroke; Warfarin | 2009 |
Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial.
Topics: Adult; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Dyspepsia; Female; Humans; Male; Middle Aged | 2013 |
5 other study(ies) available for dabigatran and Dyspepsia
| Article | Year |
|---|---|
Adherence to anticoagulant treatment with dabigatran in a real-world setting.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Capsules; Chi-Square Distribution; Cross-Sectional Studies; Dabigatran; Dyspepsia; Female; Health Knowledge, Attitudes, Practice; Hemorrhage; Humans; Interviews as Topic; Male; Medication Adherence; Patient Education as Topic; Risk Factors; Stroke; Time Factors | 2013 |
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry.
Topics: Aged; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Dyspepsia; Female; Follow-Up Studies; Hemorrhage; Humans; Italy; Male; Middle Aged; Population Surveillance; Prevalence; Prospective Studies; Registries; Risk Factors; Stroke; Thromboembolism; Treatment Outcome | 2015 |
A real world data of dabigatran etexilate: multicenter registry of oral anticoagulants in nonvalvular atrial fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Dyspepsia; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Myocardial Infarction; Registries; Stroke; Warfarin | 2016 |
Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Dyspepsia; Female; Follow-Up Studies; Hemorrhage; Humans; Italy; Male; Medication Adherence; Middle Aged; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Vitamin K | 2017 |
At last, a RE-LYable alternative to warfarin for atrial fibrillation.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Dyspepsia; Hemorrhage; Humans; Multicenter Studies as Topic; Prospective Studies; Pyridines; Randomized Controlled Trials as Topic; Warfarin | 2009 |